In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact Lens
NCT ID: NCT00584727
Last Updated: 2015-05-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2007-09-30
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear
NCT00584220
Comparison of Two Toric Contact Lenses on Current Toric Wearers
NCT00639379
Comparative Clinical Evaluation of Soft Toric Lens Designs
NCT01552876
Clinical Evaluation of Two Toric Contact Lenses in Current Non-toric Lens Users
NCT01180998
Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses
NCT05483127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
senofilcon A/alphafilcon A/etafilcon A
First intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
senofilcon A toric contact lens
contact lens
alphafilcon A toric
contact lens
etafilcon A sphere
contact lens
alphafilcon A/etafilcon A/senofilcon A
First intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses
senofilcon A toric contact lens
contact lens
alphafilcon A toric
contact lens
etafilcon A sphere
contact lens
etafilcon A/senofilcon A/alphafilcon A
First intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses
senofilcon A toric contact lens
contact lens
alphafilcon A toric
contact lens
etafilcon A sphere
contact lens
senofilcon A/etafilcon A/alphafilcon A
First intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses
senofilcon A toric contact lens
contact lens
alphafilcon A toric
contact lens
etafilcon A sphere
contact lens
alphafilcon A/senofilcon A/etafilcon A
First intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
senofilcon A toric contact lens
contact lens
alphafilcon A toric
contact lens
etafilcon A sphere
contact lens
etafilcon A/alphafilcon A/senofilcon A
First intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses
senofilcon A toric contact lens
contact lens
alphafilcon A toric
contact lens
etafilcon A sphere
contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
senofilcon A toric contact lens
contact lens
alphafilcon A toric
contact lens
etafilcon A sphere
contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy
3. have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
4. be able and willing to adhere to the instructions set forth in the protocol.
5. agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
6. have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
7. have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
8. be in good general health, based on his/her knowledge.
9. read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.
Exclusion Criteria
2. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
3. The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
4. Slit lamp findings that would contraindicate contact lens wear such as:
* Pathological dry eye or associated findings
* Pterygium or corneal scars within the visual axis
* Neovascularization \>1mm in from the limbus
* History of giant papillary conjunctivitis (GPC) worse than Grade 2
* Anterior uveitis or iritis (past or present)
* Seborrhoeic eczema, seborrhoeic conjunctivitis
5. A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
6. A known history of corneal hypoesthesia (reduced corneal sensitivity.)
7. Aphakia, keratoconus or a highly irregular cornea.
8. Current pregnancy or lactation (to the best of the subject's knowledge).
9. Active participation in another clinical study at any time during this study.
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foresight Regulatory Strategies, Inc.
INDUSTRY
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vistakon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason Chin, O.D.
Role: PRINCIPAL_INVESTIGATOR
James Fujimoto, O.D.
Role: PRINCIPAL_INVESTIGATOR
Weslie Hamada, OlD.
Role: PRINCIPAL_INVESTIGATOR
Arthur T. Kobayashi, O.D., Inc.
Dennis Kuwuabara, O.D.
Role: PRINCIPAL_INVESTIGATOR
Eye Care Associates of Hawaii
Mark Nakano, O.D.
Role: PRINCIPAL_INVESTIGATOR
Mark E. Nakano Optometric Corp.
Ikuko Sugimoto, O.D.
Role: PRINCIPAL_INVESTIGATOR
Kevin Rosin, O.D.
Role: PRINCIPAL_INVESTIGATOR
Drs. Farkas, Kassalow, Resnick & Associates
Jennifer Kao, O.D.
Role: PRINCIPAL_INVESTIGATOR
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-0714A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.